Catch up on the top radiology content of the past week.
|Articles|April 11, 2001
ADAC taps new CEO
Philips Medical Systems has appointed Gary Burbach chief executive officer of ADAC Laboratories. ADAC, a vendor of nuclear medicine equipment and radiation therapy planning systems, was acquired by Philips in December 2000. Prior to the acquisition,
Advertisement
Philips Medical Systems has appointed Gary Burbach chief executive officer of ADAC Laboratories. ADAC, a vendor of nuclear medicine equipment and radiation therapy planning systems, was acquired by Philips in December 2000. Prior to the acquisition, Burbach served as ADAC president and COO. In his role as CEO, Burbach will be responsible for ADAC global operations, reporting to Tim Mickelson, executive vice president of Philips Medical Systems and CEO of ATL Ultrasound.
Advertisement
Related to this article
In the second of a two-part interview, Kalpana Kanal, PhD, and Mahadevappa Mahesh, MS, PhD, FAPPM, FACR, discussed future directions for research on CT radiation dosing, including the potential of indication-specific diagnostic reference levels (DRLs).
In the first of a two-part podcast episode, Lauren Nicola, MD, Christoph Wald, MD, PhD, MBA, and Peter Shen discuss current challenges with reimbursement for AI in radiology.
Catch up on the latest imaging research from the recent European Society of Cardiology (ESC) Congress.
The use of adjunctive AI for pulmonary nodule assessment on chest CT exams led to over a three-minute reduction in median reporting time, according to newly reported research.
In the first of a two-part interview, Kalpana Kanal, PhD, and Mahadevappa Mahesh, MS, PhD, FAPPM, FACR, discussed recently published research showing significant declines in computed tomography (CT) radiation dosing over the past decade.
A new study shows that even small plaque volume may be associated with significantly higher risk for cardiovascular events, making the enhanced spatial resolution available with advanced imaging even more critical in risk stratification.
In comparison to contrast-enhanced CT, FAPI PET was associated with over 27 percent higher sensitivity for peritoneal carcinomatosis in the small bowel and 53 percent higher sensitivity in the upper abdomen, according to a new study involving 200 women with primary ovarian carcinoma.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Brain MRI Study Reveals Higher Brain Age Gap and White Matter Hyperintensity for Those in Disadvantaged Neighborhoods
2
Molecular Imaging in Focus: Can the Newly FDA-Approved PET Agent Floretyrosine F18 Have an Impact for Glioma Imaging?
3
The Reading Room Podcast: Assessing the Current Landscape of AI and Reimbursement in Radiology, Part 2
4
Breast Imaging in Focus: Key Pearls from New Guidelines on Proliferative Breast Lesions with Atypia and LCIS
5